News
Mumbai’s Sion Hospital to start phase-3 trials of first indigenous Covid vaccine
The Lokmanya Tilak General Hospital, also known as Sion Hospital, will soon start phase-3 clinical trials of India’s indigenous Covid-19 vaccine—COVAXINTM. As many as...
News
Aspen Pharmacare, Johnson & Johnson announce deal to produce COVID-19 vaccine candidate
South African pharmaceutical company Aspen Pharmacare on Tuesday announced its deal with the American firm Johnson & Johnson to jointly manufacture its COVID-19 vaccine...
News
CureVac COVID-19 vaccine induces immune response in early trial
German vaccine maker CureVac on Monday said that interim results from early trials showed that its investigational Covid-19 vaccine candidate, CvnCoV, appeared safe and...
News
Bharat Biotech to launch candidate in Q2 2021, Israel starts human trials
The number of cases of the coronavirus disease (Covid-19) is nearing the 50 million mark across the world and the death toll has risen...
News
Lonza Welcomes New Group Chief Executive Officer Pierre-Alain Ruffieux
Pierre-Alain Ruffieux today joins Lonza Group in the role of Chief Executive Officer. Albert Baehny has taken the role of CEO ad interim since...
Press Releases
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from clinical through commercialization, announced...
News
Novartis, Molecular Partners team up to develop DARPin therapeutics for COVID-19
Novartis and Molecular Partners AG announced a collaboration in the form of an option and license agreement to develop, manufacture and commercialize Molecular Partners’...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read